ProKidney Corp. (PROK)
USD 0.7
(14.57%)
USD 0.7
(14.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -90.06 Million | -77.08 Million | -50.29 Million | -25.18 Million | -76.8 Thousand |
| Net Income | -35.46 Million | -148.13 Million | -55.14 Million | -26.74 Million | -79.61 Thousand |
| Depreciation & Amortization | 3.16 Million | 3.03 Million | 1.98 Million | 964 Thousand | 867.00 |
| Deferred income taxes | -11.63 Million | -40.43 Million | -4.66 Million | -604.00 | - |
| Stock-based compensation | 30.84 Thousand | 74.46 Thousand | 699.00 | 730.00 | 498.00 |
| Change in working capital | 16.67 Million | -6.45 Million | 2.16 Million | -126 Thousand | -115.00 |
| Other non-cash items | -93.65 Million | 40.43 Million | 4.66 Million | 604.00 | 1559.00 |
| Investing Cash Flow | -329.98 Million | -1.73 Million | -5.19 Million | -5.45 Million | -2968.00 |
| Investments in PPE | -34.19 Million | -1.84 Million | -5.19 Million | -5.45 Million | -1305.00 |
| Acquisitions | 34.19 Million | 108 Thousand | 1000.00 | - | -1663.00 |
| Investment purchases | -471.6 Million | - | - | - | - |
| Sales/Maturities of investments | 175.81 Million | - | - | - | - |
| Other Investing Activities | -34.19 Million | 108 Thousand | 1.00 | - | - |
| Financing Cash Flow | -9.55 Million | 548.52 Million | 71.47 Million | 19.98 Million | 20 Thousand |
| Debt repayment | -52 Thousand | -35.03 Million | -30 Thousand | -11 Thousand | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -9.49 Million | - | - | - | - |
| Common Stock Issuance | - | 6.05 Million | 71.5 Million | - | - |
| Other Financing Activities | -9.49 Million | 577.5 Million | 71.5 Million | 20 Million | 20 Thousand |
| Accounts receivables | -1.37 Million | - | - | - | - |
| Accounts payables | 11.63 Million | 494 Thousand | 5000.00 | 683 Thousand | - |
| Inventory | -11.63 Million | - | - | - | - |
| Other working capital | 18.04 Million | -6.95 Million | 2.15 Million | -809 Thousand | -115.00 |
| Cash at beginning of period | 490.25 Million | 20.55 Million | 4.57 Million | 15.22 Million | - |
| Cash at end of period | 60.64 Million | 490.25 Million | 20.55 Million | 4.57 Million | 15.22 Thousand |
| Capital Expenditure | -34.19 Million | -1.84 Million | -5.19 Million | -5.45 Million | -1305.00 |
| Effect of forex changes on cash | - | - | - | - | 75 Thousand |
| Net cash flow / Change in cash | -429.6 Million | 469.69 Million | 15.98 Million | -10.64 Million | 15.22 Thousand |
| Free Cash Flow | -124.26 Million | -78.93 Million | -55.49 Million | -30.63 Million | -78.11 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.5 Million | -9.49 Million | -5.7 Million | -35.46 Million | -41.99 Million | -34.82 Million |
| Depreciation & Amortization | 964 Thousand | 832 Thousand | 1.03 Million | 3.16 Million | 1 Million | 870 Thousand |
| Deferred income taxes | - | - | 3.64 Million | -11.63 Million | - | 9.71 Million |
| Stock-based compensation | 7.81 Million | 7679.00 | -6.37 Million | 30.84 Thousand | 12.99 Thousand | 11.2 Thousand |
| Change in working capital | -7.52 Million | -5.8 Million | 3.9 Million | 16.67 Million | 5.89 Million | 9.32 Million |
| Other non-cash items | -16.45 Million | -17.98 Million | -21.89 Million | -93.65 Million | -1.67 Million | -11.2 Million |
| Investing Cash Flow | 28.57 Million | 58.39 Million | -95.84 Million | -329.98 Million | -28.37 Million | -13.15 Million |
| Investments in PPE | -636 Thousand | -960 Thousand | -1.57 Million | -34.19 Million | -27.93 Million | -3.7 Million |
| Acquisitions | - | - | 94.27 Thousand | 34.19 Million | 435.00 | 9453.00 |
| Investment purchases | -27.46 Million | -55.41 Million | -169.9 Million | -471.6 Million | -39.85 Million | -63.8 Million |
| Sales/Maturities of investments | 56.67 Million | 114.77 Million | 75.63 Million | 175.81 Million | 39.41 Million | 54.35 Million |
| Other Investing Activities | 29.2 Thousand | 59.35 Thousand | -94.27 Thousand | -34.19 Million | -435.00 | -9453.00 |
| Financing Cash Flow | 139.84 Million | -13 Thousand | -9.51 Million | -9.55 Million | -13 Thousand | -13 Thousand |
| Debt repayment | -13 Thousand | -13 Thousand | -13 Thousand | -52 Thousand | -13 Thousand | -13 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -9.49 Million | -9.49 Million | - | - |
| Common Stock Issuance | 139.85 Million | - | - | - | - | - |
| Other Financing Activities | 139.85 Thousand | - | -9.49 Million | -9.49 Million | - | -13.00 |
| Accounts receivables | -844 Thousand | -529 Thousand | -661 Thousand | -1.37 Million | 7.37 Million | -2.61 Million |
| Accounts payables | 104 Thousand | -5.94 Million | 3.86 Million | 11.63 Million | -4.65 Million | 13.03 Million |
| Inventory | - | - | -3.86 Million | -11.63 Million | -7.37 Million | 2.61 Million |
| Other working capital | -6.67 Million | -5.28 Million | 4.56 Million | 18.04 Million | 10.54 Million | -3.7 Million |
| Cash at beginning of period | 84.38 Million | 60.64 Million | 191.38 Million | 490.25 Million | 243.55 Million | 271.63 Million |
| Cash at end of period | 214.5 Million | 84.38 Million | 60.64 Million | 60.64 Million | 191.38 Million | 243.55 Million |
| Capital Expenditure | -636 Thousand | -960 Thousand | -1.57 Million | -34.19 Million | -27.93 Million | -3.7 Million |
| Effect of forex changes on cash | - | - | -39.28 Million | - | - | 39.28 Million |
| Net cash flow / Change in cash | 130.11 Million | 23.74 Million | -130.74 Million | -429.6 Million | -52.16 Million | -28.08 Million |
| Free Cash Flow | -38.92 Million | -35.6 Million | -26.95 Million | -124.26 Million | -51.71 Million | -18.61 Million |
KCPSUGIND
SRXXF
APLT
FBSE
300645
TMASF